Skip to main content
PLOS One logoLink to PLOS One
. 2025 Jan 24;20(1):e0317083. doi: 10.1371/journal.pone.0317083

Mathematical and statistical approaches in epidemiological investigation of hospital infection: A case study of the 2015 Middle East Respiratory Syndrome outbreak in Korea

Youngsuk Ko 1, Eunok Jung 2,*
Editor: Yury E Khudyakov3
PMCID: PMC11759389  PMID: 39854481

Abstract

Mathematical and statistical methods are invaluable in epidemiological investigations, enhancing our understanding of disease transmission dynamics and informing effective control measures. In this study, we presented a method to estimate transmissibility using patient-level data, with application to the 2015 MERS outbreak at Pyeongtaek St. Mary’s Hospital, the Republic of Korea. We developed a stochastic model based on individual case data to derive a likelihood function for disease transmission. Through scenario-based analysis, we explored transmission dynamics, including the role of superspreaders, and investigated how mask-wearing impacted infection control within the hospital. Our findings indicated that the superspreader during the MERS outbreak had approximately 25 times higher transmissibility compared to other patients. Under scenarios of prolonged hospital transmission periods, the number of cases could potentially increase threefold. The impact of mask-wearing in the hospital was significant, with reductions in the epidemic scale ranging from 17% to 77%, depending on the type of mask and intervention intensity. This study quantifies key risk factors in hospital-based transmission, demonstrating the effectiveness of intervention measures. The methodology developed here can be readily adapted to other infectious diseases, providing valuable insights for future outbreak preparedness and response strategies.

Introduction

An epidemiological investigation is a systematic method used to determine the cause, source, and spread of a disease within a population, usually following an unusual increase in the number of cases [1, 2]. This process typically involves steps like verifying the outbreak, defining and identifying additional cases, using epidemiological methods to understand the disease transmission dynamics, and collecting data pertaining to cases, their characteristics, and potential risk factors [2, 3].These data are directly utilized to estimate model parameters and simulate realistic outbreak patterns. This allows for evidence-based implementation of control measures to prevent further spread of the disease and reduce the risk of future outbreaks [3, 4].

Mathematical and statistical approaches enhance the significance of epidemiological investigations. Information aggregated through these investigations can be processed to understand the unique characteristics of specific infectious diseases, such as their incubation or latent periods, and presented as statistical distributions to aid future research [57]. For instance, during the COVID-19 pandemic in South Korea, detailed epidemiological information on individual cases—including estimated exposure dates, symptom onset dates, and reporting dates—was collected and analyzed using mathematical and statistical methods until the Omicron variant became dominant [811]. These analyses revealed changes in contact patterns between age groups during COVID-19 pandemic, which differed from those observed before the pandemic. This information was then used for short- and long-term predictions, considering factors such as vaccine prioritisation and policy decisions. By integrating epidemiological investigations with mathematical and statistical analyses, this approach provides evidence that enhances the reliability and accuracy of model results [813].

In this study, we introduce a process for interpreting epidemiological investigations using mathematical and statistical methods to estimate key parameters and transmission rates. As a case study, we apply this method to an outbreak at Pyeongtaek St. Mary’s Hospital (PMH), the initial site of hospital transmission during the 2015 Middle East Respiratory Syndrome (MERS) outbreak in Korea, where 36 out of 186 total cases were identified [1416]. Studies conducted in endemic regions described the transmission pathways originating from environmental factors, progressing to human hosts, and ultimately reaching healthcare facilities [1719]. Our research focused on non-endemic regions where such intermediate host transmission may not play a significant role. To investigate transmission rates in detail, we categorized individuals into superspreaders, healthcare workers (HCWs), patients, and visitors based on actual epidemiological investigations. The spread in Korea was largely due to superspreaders, patients who caused secondary infections in more than six people [2023]. Of the 186 cases, it was suspected that 15 transmitted the disease to others, with five identified as superspreaders.

Simultaneously with the estimation of the transmission rate, we developed a model that reflects these investigations and simulates a realistic outbreak.A scenario-based analysis was introduced to quantify risk factors such as the infectious period of infected individuals, including superspreaders, and the effectiveness of mask mandates within the hospital. The methodology employed in this study transforms the dynamics of hospital infections into a likelihood function, allowing for its application to other hospitals or infectious disease outbreaks. By focusing on the estimation of transmission rates among heterogeneous hosts in certain spaces like hospitals, we expect these findings to significantly enhance both reactive and preventive measures. This approach, which has been successfully utilized in various contexts, including human-to-human and animal-to-animal infectious diseases, underscores the potential for improving infection control strategies [811, 24, 25].

Materials and methods

Probabilities and likelihoods during the outbreak

Two necessary pieces of information expected from the epidemiological investigation are: (1) when were the infectious individuals suspected of transmitting the disease and (2) when were the infected individuals infected with the disease (or the time range in which they were exposed to the disease). These factors influence the probability of individuals becoming infected at certain time points. Let us consider a classic SIR model formulated using ordinary differential equations for a susceptible population [26]. A susceptible host can be infected by an infectious host at a rate β. Let N indicate the total number of hosts. When assuming frequency-dependent transmission, ignoring natural birth and death [27], and fixing the number of infectious hosts as NI (estimated based on the first piece of information gathered from the epidemiological investigation mentioned above), the following equation is obtained:

dSdt=-βSNIN. (1)

This equation transitions to a linear form, facilitating a straightforward resolution. Given the assumption that the initial S is one to consider the status of a single host and N is a constant, the equation is solved as follows:

S(t)=exp(-βSNINt). (2)

This solution represents the probability that the host remains in the susceptible state for up to time t. When considering a unit of time, defined as t = 1, the subsequent probability is conceptualized as follows [2830]:

qS=exp(-βSNIN). (3)

In this framework, qS is interpreted as the probability of a host maintaining an uninfected status over a unit of time. Conversely, the probability of a host becoming infected is represented as qI, and expressed as follows:

qI=1-qS=1-exp(-βSNIN). (4)

Let us consider a situation in which multiple hosts coexist, as shown in Fig 1. At time t, there are N hosts in total, with NS susceptible and NI infectious hosts. After a unit of time (t+ 1), if X hosts are infected and Y hosts are not infected (X+ Y = N), using previously calculated probabilities, we can calculate the following likelihood function (L):

L=i=1Xexp(-βSNIN)×i=1Y(1-exp(-βSNIN)). (5)

Fig 1. Derivation of the likelihood function for a unit timestep considering both unsuccessful and successful disease transmissions.

Fig 1

Since the epidemiological investigation is based on actual incidences, the value of β that maximizes this likelihood function can represent the reality. Therefore, our goal is to determine the value of β that maximizes L. In this study, the Metropolis-Hastings algorithm was used to sample the parameters to find the value of β [31]. This explanation describes progress in one unit of time, whereas the actual case application considers multiple unit time steps and is expressed as the product of all probabilities. To apply this method to real data, the exact time range of exposure for each host is required, which is the second piece of information mentioned at the beginning of this subsection.

Application of maximum likelihood estimation (MLE) to MERS nosocomial spread in Korea and model formulation

Infectious hosts transmit the disease through viral shedding. We assumed that there is heterogeneity in the successful transmission based on contact frequency, duration, and distance between the infectee and infector, considering the types of hosts (HCWs, patients, and visitors) within the hospital setting. Note that this study only considers human-to-human transmission, as the Republic of Korea is not located in an endemic region. Kim provided insights into individual hosts considering their types, encompassing their anticipated exposure times, expected transmission times, isolation times, and the number of individuals present in PMH during the 2015 MERS outbreak in Korea [14]. Let βAB denote the transmission rate, where the subscripts A and B indicate the infector and infectee types, respectively. Symbols Ω, H, P, and V as subscripts indicating the types of hosts as superspreaders, HCWs, patients, and hospital visitors, respectively. We classified individuals as either infected or uninfected. The groups of infected and uninfected individuals are represented as ΛI, and ΛS, respectively. Let Di and D˜i be the identifiers for the types of hosts in ΛS and ΛI, respectively, and T be the discrete time points. Considering the number of infectors at a specific time k is Ij(k), where the subscript j indicates the host type, the likelihood of hosts in ΛS and ΛI is derived as follows:

LS=iΛS{kTexp(j{Ω,H,P,V}-βjDiIj(k)N)},LI=iΛI{kT(1-exp(j{Ω,H,P,V}-βjD˜iIj(k)N))},L(B)=LS×LI,whereB={βHH,βHP,βHV,βPH,βPP,βPV,βVH,βVP,βVV,βΩH,βΩP,βΩV}. (6)

Our goal is to find B that maximises L(B). Note that βHH, βHP, and βHV are set to zero because the epidemiological investigation showed that there was no contagious period involving HCWs in PMH. In addition, symmetric transmission between patients and visitors was assumed, i.e., βPV = βVP.

In this study, we developed a susceptible-exposed-infectious-recovered (SEIR)-type model to investigate nosocomial spread, and Fig 2 provides a visual representation of our model. There were five stages of disease progression: susceptible (S), exposed (E), infectious (I), isolated (Q), and recovered (R). The subscripts indicate the types of hosts introduced. We categorized the events that could occur during an outbreak into delayed (non-Markovian) and nondelayed (Markovian). The event where a susceptible host is exposed to infection is assumed to be Markovian since it does not involve past points in time, while all other events are assumed to be non-Markovian as they are strongly influenced by past points in time. For example, the symptom onset after exposure is significantly affected by the past exposure point. Fig 2 illustrates the different types of reactions: the non-Markovian process (transition from disease exposure, dashed line with an arrow) and the Markovian process (solid line with an arrow). To incorporate the infectious period of the hosts into the model simulation, we fitted the data assuming a gamma distribution for the samples using the built-in MATLAB function fitdist [32, 33]. The distribution of the delay from disease exposure to symptom onset was estimated with shape and scale parameters of 4.45 and 1.57 respectively, resulting in a mean of 6.99. For the delay from symptom onset to isolation, the estimated shape and scale parameters were 2.24 and 2.47 respectively, with a mean of 3.70. We assumed a fixed delay of 14 days from isolation to recovery [34].

Fig 2. Flow diagram of the MERS intra-hospital transmission model.

Fig 2

By applying the estimated parameters and distributions, simulations were conducted using the modified Gillespie algorithm with 10,000 simulation runs for each scenario setting [35, 36]. To reflect the actual events in Korea, the superspreader was designated to stay in PMH for 3 days (May 15–17, 2015). The initial numbers of susceptible HCWs, patients, and visitors were 241, 263, and 389, respectively [14]. The values in Table 1 represent the population distribution for the infectious period [33]. However, due to factors such as isolation measures and ward closures in the hospital, the infectious period was adjusted by 25% (75% reduction) for use in the baseline scenario simulation [14, 34]. This adjustment ensured that the mean number of confirmed cases from the simulations matched the actual number of cases. The results for the adjustment ratio are introduced in the following section.

Table 1. Description of reactions in the MERS intra-hospital transmission model.

Event Reaction dest Reference
Infection of HCW Markovian Propensity:
SHβHHIH+βPHIP+βVHIV+βΩHIΩN
Fitted
Infection of patient Markovian Propensity:
SPβHPIH+βPPIP+βVPIV+βΩPIΩN
Fitted
Infection of visitor Markovian Propensity:
SVβHVIH+βPVIP+βVVIV+βΩVIΩN
Fitted
Symptom onset Non-Markovian Delay: gamma distribution,
Mean: 6.99
Mean: 3.31
[33]
Isolation Non-Markovian Delay: gamma distribution,
Mean: 5.53
Mean: 3.70
[33]
Recovery Non-Markovian Delay: fixed as 14 [34]

Since the onset of the Coronavirus disease pandemic, the wearing of masks in health facilities has been legally enforced until April 2024 [37]. To quantify the effect of mask-wearing on preventing nosocomial spread, we conducted an additional scenario-based analysis. Parameters that had a significant impact on nosocomial spread were considered, and the following three scenarios were analysed:

  • Analysis of the infectious period of hosts in the hospital: We adjusted the infectious period of the total population from 0% to 95% in our baseline scenario, which had already reduced it by 75%. The infectious period of the superspreader was fixed at 3 days.

  • Analysis of adjusting the infectious period of a superspreader: We considered the infectious period for non-superspreaders as the baseline and adjusted the infectious period of the superspreader from 1 to 5 days.

  • Analysis of mask-wearing interventions: We evaluated the impact of the mask mandate in hospitals. The effect varied according to the type of mask (76% for N95 and 30% for medical/surgical masks) and the level of enforcement (full effect for mandatory, half for recommended) [38]. The preventive effect of wearing a mask is reflected in a reduction in the force of infection in susceptible hosts.

Results

Estimation of transmission rates

The parameters sampled using the Metropolis-Hastings algorithm are represented in the form of box-whisker plots in Fig 3. Fig 3(A) and 3(B) show the transmission rates of non-superspreaders and superspreaders, respectively. The mean values of sampled transmission rates βPH, βPP, βPV, βVH, and βVV were 0.04, 0.61, 0.01, 0.17, 0.01, and 0.05 (95% credible interval (CrI) [0.00, 0.12], [0.42, 0.84], [0.00, 0.05], [0.01, 0.49], and [0.00, 0.16]), respectively, among which the transmission rate between patients (βPP) was estimated to be the highest. The mean superspreader-induced transmission rates βΩH, βΩP, and βΩV were estimated to be 4.27, 15.04, and 10.57 (95% CrI [1.69, 7.97], [9.89, 21.19], and [7.09, 14.82]). The superspreader-induced transmission rate among patients was estimated to be the highest.

Fig 3. Distribution of sampled transmission rates in Pyeongtaek St. Mary’s Hospital during the 2015 MERS outbreak in Korea.

Fig 3

(A) Transmission rates induced by non-superspreaders, (B) transmission rates induced by a superspreader.

Simulation of the baseline scenario

The simulation results for the baseline scenario are shown in Fig 4. Fig 4(A) shows the cumulative number of confirmed cases over time. The grey area in the graph represents the 95% confidence interval (CI), and the dark curve indicates the mean of the simulation runs. Fig 4(B) shows the distribution of confirmed cases. The mean number of confirmed cases was 36.12, which was close to the actual number of cases (36), and the 95% CI was from 23 to 50. The state variables E, I, and Q are visualised in Fig 4(C), and the prevalence (proportion of E, I, and Q in the total population) is represented in Fig 4(D). Based on the mean, we observed that E, I, and Q reached 28.62, 4.73, and 31.42 (3.3, 8.1, and 18.2 days after primary case onset). The possible peak in the 95% CI prevalence was 6%.

Fig 4. Baseline simulation results of the number of confirmed cases.

Fig 4

(A) Cumulative confirmed cases over time, (B) distribution of the confirmed cases from simulation runs, (C) number of exposed, infectious, and isolated hosts over time, and (D) prevalence (proportion of exposed, infectious, and isolated hosts) over time. In panels A, B, and C, solid curves indicate mean value and coloured areas indicate 95% CI.

Scenario-based study

To conduct the baseline scenario simulation, we reduced the infectious period by 75% compared to the population distribution, which includes the suspected infectious period outside the hospital, such that the mean value of the simulation runs follows the actual number of cases. Fig 5 shows the mean and 95% CI of the confirmed cases, indicated by reduction varying from 0% to 95%. The cyan dotted vertical line indicates the value used in the baseline scenario, and the magenta horizontal dotted line represents the actual number of confirmed cases. The mean (95% CI) number of confirmed cases changed from 100.40 ([39, 140]) to 30.70 ([22, 47]) as the reduction factor varies from 0% to 95%.

Fig 5. Number of confirmed cases varying with change in the infectious period reduction.

Fig 5

Dark curve indicates simulation mean and red area covers 95% CI.

In the baseline scenario, the infectious period of the superspreader was fixed at 3 days. To observe the impact on the scale of the outbreak when this period varies between 1 and 5 days, Fig 6 shows the distribution of confirmed cases according to the infectious period of the superspreader. The number of confirmed cases ranged from a minimum mean of 13.01 (95% CI [6, 23]) to a maximum of 57.84 (95% CI [41, 76]).

Fig 6. Distribution of the number of confirmed cases of the model simulation runs for the varying infectious period of a superspreader (1 to 5 days).

Fig 6

Note that the distribution of baseline scenario simulation runs (3 days of infectious period) is not included in this figure.

Preventive effect of mask mandates

The results of the simulations considering the mask mandates are visualised in Fig 7. Fig 7(A) indicates the type of mask worn by HCWs, patients, and visitors for each detailed scenario. Fig 7(B) presents the simulation results considering mask mandates for each detailed scenario as an odds ratio of the number of confirmed cases compared with the baseline scenario, where mask mandates are not applied. The mean effect varied depending on the type of mask (N95 and medical or surgical masks), at 76% and 30%, respectively [38].

Fig 7. Simulation results of scenarios considering different mask mandates.

Fig 7

(A) Description of scenario set-up, (B) odds ratio of confirmed cases. Recommendation level of intervention indicates that preventive effect of mask-wearing is reduced by half.

The highest reduction in the number of confirmed cases by mean 77% was achieved in the case of mandatory wearing of N95 or equivalent masks for everyone in the hospital. The lowest effect was achieved when recommending medical or surgical masks to everyone in the hospital, resulting in a mean reduction of 17% in the number of confirmed cases.

Discussion

During the MERS outbreak in 2015, the transmission rate in PMH was estimated to be the highest among patients, which was attributed to the spread originating from the inpatient ward. Similarly, the transmission rate induced by the superspreader was highest among patients, followed by visitors and then HCWs. The estimated transmission rate directly shows the risk of the spread of infectious diseases in hospitals. Excluding the superspreader, the mean transmission rate of 0.61 can be interpreted as the possibility of an additional 0.61 infections occurring per day by a single infectious patient.

The results of the baseline scenario simulation primarily show uncertainty in the scale of the outbreak, indicating that there could have been a minimum of 23 and up to 50 confirmed cases (Fig 3). Additionally, Fig 4(C) and 4(D) show the point at which the prevalence within the hospital was expected to be greatest, which is 8 days after the onset in the baseline scenario. This indicates the time when the most infectious hosts were present. Paradoxically, this necessitates recognising the outbreak and tracking the infected individuals before the date when the spread within the hospital is most likely to occur.

Additional scenario-based analyses demonstrated the importance and potential of efforts to prevent the spread within the hospital. If the entire duration from symptom onset to isolation of infected individuals occurred within the hospital, meaning the reduction rate of the transmission period is 0% (Fig 5), there could have been more than 100 infected individuals in PMH alone. Moreover, if the period in which a single superspreader stayed in the hospital was extended to 5 days (an increase of 2 days compared to reality; Fig 6), there could have been 61% more cases.

Since the onset of the COVID-19 pandemic, mask mandates have been strongly implemented in Korea, and as of March 2024, it is mandatory to wear masks in hospitals. The results of this study show that maintaining such interventions has a significant effect on preventing the spread of infectious diseases within hospitals. The study also provides appropriate mask intervention strategies depending on the level of spread prevention goals. For example, to maintain the prevention of infectious disease spread in hospitals at more than 50%, it is essential to take protective measures for HCWs and patients (Fig 7).

The limitations of this study are as follows. (1) Detailed spaces within the hospital, such as wards and rooms, were not considered. (2) The effect of non-pharmaceutical interventions was modeled as an average. (3) Visitors entering and exiting the hospital were not considered. (4) Transmission by healthcare workers (HCWs) was assumed to be negligible. (5) We assumed a frequency-dependent transmission pattern within hospitals.

In this study, we focused on a single hospital context and did not include health-seeking behaviors—such as visiting multiple healthcare facilities, often called ‘doctor shopping’—which significantly contributed to the cross-hospital spread during the 2015 MERS outbreak in the Republic of Korea [14, 39]. Addressing this and other complexities, such as detailed spatial arrangements, individual patient tracking, isolation and testing procedures, and infections involving HCWs, would allow for a more comprehensive model. Future work will expand on these elements, incorporating diverse transmission types and behaviors to better capture the dynamics of healthcare-associated outbreaks.

Additionally, our methodology could be adapted to other outbreaks in closed settings, such as those documented early in the COVID-19 pandemic in the Republic of Korea, in environments like hospitals, nursing homes, and correctional facilities [4042]. With access to individual case data specific to each location, we believe our approach could be effectively applied to analyze similar scenarios. Furthermore, as recorded in endemic regions, future studies will highlight the transmission pathways moving from environmental sources to humans and subsequently to healthcare facilities.

Conclusion

This study encapsulates the process of estimating transmission rates using information collected from epidemiological investigations, specifically the suspected duration of the infectious period and the disease exposure time of individuals. By using the Metropolis-Hastings algorithm for parameter estimation, we were able to present the transmission rates as distributions, illustrating the uncertainty in the transmission rate of the underlying data.

The overall methodology of this study can be applied to other outbreak situations, where it will yield different results due to spatial characteristics when applied to different countries, hospitals, or regions. This will help in ensuring preparedness and establishing intervention policies that can be tailored to the specific conditions in future outbreak situations.

Data Availability

The data that support the findings of this study are openly available in figshare at https://doi.org/10.6084/m9.figshare.25981987.v1.

Funding Statement

This paper was supported by Konkuk University in 2022 in the form of funding awarded to EJ.

References

  • 1. Bonita R, Beaglehole R, Kjellström T. Basic epidemiology. World Health Organization; 2006. [Google Scholar]
  • 2. Rasmussen SA, Goodman RA. The CDC field epidemiology manual. Oxford University Press; 2018. [Google Scholar]
  • 3.King ME, Bensyl DM, Goodman RA, Rasmussen SA. Conducting a Field Investigation. Centers for Disease Control and Prevention: Atlanta, GA, USA. 2018;
  • 4. Rothman KJ. Epidemiology: an introduction. Oxford university press; 2012. [Google Scholar]
  • 5. Lee RM, Lessler J, Lee RA, Rudolph KE, Reich NG, Perl TM, et al. Incubation periods of viral gastroenteritis: a systematic review. BMC Infect Dis. 2013;13:1–11. doi: 10.1186/1471-2334-13-446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. McAloon C, Collins Á, Hunt K, Barber A, Byrne AW, Butler F, et al. Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open. 2020;10(8):e039652. doi: 10.1136/bmjopen-2020-039652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291–300. doi: 10.1016/S1473-3099(09)70069-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Shim E, Choi W, Song Y. Clinical time delay distributions of COVID-19 in 2020–2022 in the Republic of Korea: inferences from a nationwide database analysis. J Clin Med. 2022;11(12):3269. doi: 10.3390/jcm11123269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Ko Y, Lee J, Seo Y, Jung E. Risk of COVID-19 transmission in heterogeneous age groups and effective vaccination strategy in Korea: a mathematical modeling study. Epidemiology and Health. 2021;43. doi: 10.4178/epih.e2021059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ko Y, Lee J, Kim Y, Kwon D, Jung E. COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea. Int J Environ Res Public Health. 2021;18(12):6469. doi: 10.3390/ijerph18126469 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Ko Y, Mendoza VMP, Seo Y, Lee J, Kim Y, Kwon D, et al. Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against Covid-19 epidemic in the Republic of Korea: mathematical model-based Approach considering age groups and the delta variant. Math Model Nat Phenom. 2022;17:39. doi: 10.1051/mmnp/2022024 [DOI] [Google Scholar]
  • 12. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford university press; 1991. [Google Scholar]
  • 13. Hazelbag CM, Dushoff J, Dominic EM, Mthombothi ZE, Delva W. Calibration of individual-based models to epidemiological data: A systematic review. PLoS computational biology. 2020. May 11;16(5):e1007893. doi: 10.1371/journal.pcbi.1007893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. Journal of Hospital Infection. 2017;95(2):207–13. doi: 10.1016/j.jhin.2016.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health. 2015;37. doi: 10.4178/epih/e2015033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Kim KM, Ki M,Cho S il, Sung M, Hong JK, Cheong HK, et al. Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary’s Hospital. Epidemiol Health. 2015;37. doi: 10.4178/epih/e2015041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East respiratory syndrome coronavirus transmission. Emerging infectious diseases. 2020. Feb;26(2):191. doi: 10.3201/eid2602.190697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. The Lancet. 2013. Aug 24;382(9893):694–9. doi: 10.1016/S0140-6736(13)61492-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases. 2013. Sep 1;13(9):752–61. doi: 10.1016/S1473-3099(13)70204-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kang CK, Song KH, Choe PG, Park WB, Bang JH, Kim ES, et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea. J Korean Med Sci. 2017;32(5):744. doi: 10.3346/jkms.2017.32.5.744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005. Nov 17;438(7066):355–9. doi: 10.1038/nature04153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Cho SY, Kang JM, Ha YE, Park GE, Lee JY, Ko JH, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. The Lancet. 2016. Sep 3;388(10048):994–1001. doi: 10.1016/S0140-6736(16)30623-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Park JE, Jung S, Kim A, Park JE. MERS transmission and risk factors: a systematic review. BMC public health. 2018. Dec;18:1–5. doi: 10.1186/s12889-018-5484-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Keeling MJ, Woolhouse ME, Shaw DJ, Matthews L, Chase-Topping M, Haydon DT, et al. Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science. 2001. Oct 26;294(5543):813–7. doi: 10.1126/science.1065973 [DOI] [PubMed] [Google Scholar]
  • 25. Boender GJ, Hagenaars TJ, Bouma A, Nodelijk G, Elbers AR, de Jong MC, et al. Risk maps for the spread of highly pathogenic avian influenza in poultry. PLoS computational biology. 2007. Apr;3(4):e71. doi: 10.1371/journal.pcbi.0030071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics. Proceedings of the royal society of london Series A, Containing papers of a mathematical and physical character. 1927;115(772):700–21. [Google Scholar]
  • 27. Begon M, Bennett M, Bowers RG, French NP, Hazel SM, Turner J. A clarification of transmission terms in host-microparasite models: numbers, densities and areas. Epidemiol Infect. 2002;129(1):147–53. doi: 10.1017/s0950268802007148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Dietz K, Schenzle D. Proportionate mixing models for age-dependent infection transmission. Journal of mathematical biology. 1985. Jun;22:117–20. doi: 10.1007/BF00276550 [DOI] [PubMed] [Google Scholar]
  • 29.Becker NG. Analysis of infectious disease data. Chapman and Hall/CRC; 2017 Nov 22.
  • 30. Ssematimba A, Okike I, Ahmed GM, Yamage M, Boender GJ, Hagenaars TJ, et al. Estimating the between‐farm transmission rates for highly pathogenic avian influenza subtype H5N1 epidemics in Bangladesh between 2007 and 2013. Transboundary and emerging diseases. 2018. Feb;65(1):e127–34. doi: 10.1111/tbed.12692 [DOI] [PubMed] [Google Scholar]
  • 31. Chib S, Greenberg E. Understanding the metropolis-hastings algorithm. Am Stat. 1995;49(4):327–35. doi: 10.1080/00031305.1995.10476177 [DOI] [Google Scholar]
  • 32.Bowman AW, Azzalini A. Applied smoothing techniques for data analysis: the kernel approach with S-Plus illustrations. Vol. 18. OUP Oxford; 1997.
  • 33. Virlogeux V, Park M, Wu JT, Cowling BJ. Association between severity of MERS-CoV infection and incubation period. Emerg Infect Dis. 2016;22(3):526. doi: 10.3201/eid2203.151437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.2015 MERS white paper. Ministry of Health and Welfare, Republic of Korea; 2016.
  • 35. Gillespie DT. Exact stochastic simulation of coupled chemical reactions. J Phys Chem. 1977;81(25):2340–61. doi: 10.1021/j100540a008 [DOI] [Google Scholar]
  • 36. Anderson DF. A modified next reaction method for simulating chemical systems with time dependent propensities and delays. J Chem Phys. 2007;127(21). doi: 10.1063/1.2799998 [DOI] [PubMed] [Google Scholar]
  • 37.Starting today, you don’t have to wear a mask in the hospital… COVID-19 crisis level downgraded to ‘concern’, https://www.korea.kr/news/policyFocusView.do?newsId=148928706&bbsKey=&pageIndex=1&pkgId=49500742&pkgSubId=&pkgSubs=&exceptNewsId=&cardYn=&cateId=&cateIds=&sectId=&sectIds=&nCateIds=&nSectIds=&dataValue=&srchWord=&repCode=&repText=; 2024 [accessed 3 June 2024].
  • 38. Kim MS, Seong D, Li H, Chung SK, Park Y, Lee M, et al. Comparative effectiveness of N95, surgical or medical, and non‐medical facemasks in protection against respiratory virus infection: A systematic review and network meta‐analysis. Rev Med Virol. 2022;32(5):e2336. doi: 10.1002/rmv.2336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Kim SW, Park JW, Jung HD, Yang JS, Park YS, Lee C, et al. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clinical Infectious Diseases. 2017. Mar 1;64(5):551–7. doi: 10.1093/cid/ciw768 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Lee HA, Ahn MH, Byun S, Lee HK, Kweon YS, Chung S, et al. How COVID-19 affected healthcare workers in the hospital locked down due to early COVID-19 cases in Korea. Journal of Korean Medical Science. 2021. Dec 6;36(47). doi: 10.3346/jkms.2021.36.e325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Giri S, Chenn LM, Romero-Ortuno R. Nursing homes during the COVID-19 pandemic: a scoping review of challenges and responses. European Geriatric Medicine. 2021. Dec;12(6):1127–36. doi: 10.1007/s41999-021-00531-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Lee HY, Park YJ, Yu M, Park H, Lee JJ, Choi J, et al. Accuracy of rapid antigen screening tests for SARS-CoV-2 infection at correctional facilities in Korea: March-May 2022. Infection & Chemotherapy. 2023. Dec;55(4):460. doi: 10.3947/ic.2023.0059 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Yury E Khudyakov

21 Oct 2024

PONE-D-24-28130Mathematical and Statistical Approaches in Epidemiological Investigation of Hospital Infection: A Case Study of the 2015 Middle East Respiratory Syndrome Outbreak in KoreaPLOS ONE

Dear Dr. Jung,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your manuscript was reviewed by three experts in the field. The reviewers identified several important problems in your submission. Please review carefully the attached comments and provide point-by-point responses.

Please submit your revised manuscript by Dec 05 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yury E Khudyakov, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This research was supported by the Government-wide R&D Fund Project for Infectious Disease Research (GFID), Republic of Korea (grant No. HG23C1629). This paper is supported by the Korea National Research Foundation (NRF) grant funded by the Korean government (MEST) (NRF-2021R1A2C100448711)." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This research was supported by the Government-wide R&D Fund Project for Infectious Disease Research (GFID), Republic of Korea (grant No. HG23C1629). This paper is supported by the Korea National Research Foundation (NRF) grant funded by the Korean government (MEST) (NRF-2021R1A2C100448711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

This is an interesting study and it enhances the existing knowledge base on modeling and parameter estimation. However, you need improve on the writing style for better content flow. Also always avoid copy-paste verbatim of content.

Reviewer #2: The study “Mathematical and statistical approaches in epidemiological investigation of hospital infection: A case study of the 2015 Middle East Respiratory Syndrome outbreak in Korea” aims to introduce a process for interpreting epidemiological investigations using mathematical and statistical methods to estimate key parameters and transmission rates.

Line 14-16: “For example, during the Coronavirus disease 2019 (COVID-19) pandemic… [8-11]”. Does the statement refer to the COVID-19 pandemic worldwide or only isolated to Korea? In the four cited references there are studies only from Korea.

Line 19-21: “By integrating epidemiological investigations… of model results”. Is this an assumption or a statement? If it is a statement, please add the reference.

Line 24-27: “As a case study, we apply this method to an outbreak at Pyeongtaek… where 36 out of 186 total cases were identified [12–14]”. According to reference 12, the 186 cases (36 death and 138 recovered cases) were reported until July 26, 2015. According to figure 2 from reference 12 "Distribution of transmission of Middle East respiratory syndrome coronavirus clusters and suspected super spreaders in South Korea (20th May to 25th November 2015)" the epidemiological analysis was carried out. What is the new information presented in your study?

Line 27-30: “The spread in Korea… than six people [15]. Of the 186 cases, it was suspected that 15 transmitted the disease to others, with five identified as superspreaders.” The "super-spread" terminology used in the text was taken from reference 15. Please add the appropriate reference.

Line 36-38: “The methodology used in this study, which relatively easily transforms the situation of hospital infections into a likelihood function, can be applied to other hospitals or infectious disease outbreaks.” Is this sentence an assumption or is it demonstrated by other articles that use this method for other infectious diseases?

Line 230-234: “The overall methodology of this study can be applied to other outbreak situations… to the specific conditions in future outbreak situations.” Considering that the present study was submitted in 2024, after the WHO declared that the COVID-19 pandemia had ended, I would have liked you to compare MERS and SARS-CoV-2 in the perspective in which the methodology used can be inter-connected.

Strong points:

- the methodology used by the authors is very good, clear and applicable;

- the mathematical approach used in this study is very useful for the prevention, analysis and establishment of biosecurity procedures.

Weak points:

- most of the epidemiological analysis was published in references 12 to 15;

- the images do not have a satisfactory clarity.

Reviewer #3: The author tried to demonstrate the mathematical and statistical approaches using historical data of the MERS outbreak in S. Korea.

It is well known that the MERS outbreak in South Korea was an explosive outbreak in healthcare settings which needs more demonstrated in the text and added in the model. The outbreak largely relied on the patient's health-seeking behaviors, so it should be reflected in their model.

Furthermore, the transmission also relies on the viral shedding in the infector and infectee; thus this factor should be reflected in the author's model.

I would strongly recommend the author read the article (PMID: 31961300) and incorporate the transmission dynamic in the author's model which primarily considers mathematics.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Amos Ssematimba

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer report_PONE-D-24-28130.docx

pone.0317083.s001.docx (16.7KB, docx)
PLoS One. 2025 Jan 24;20(1):e0317083. doi: 10.1371/journal.pone.0317083.r002

Author response to Decision Letter 0


24 Nov 2024

Reviewer #1:

This is an interesting study and it enhances the existing knowledge base on modeling and parameter estimation. However, you need improve on the writing style for better content flow. Also always avoid copy-paste verbatim of content.

Answer

We revised the paper to improve readability and avoid any potential controversy. Following are example revised parts:

Abstract: We revised the abstract section as follows for better readability and structure:

Mathematical and statistical methods are invaluable in epidemiological investigations, enhancing our understanding of disease transmission dynamics and informing effective control measures. In this study, we presented a method to estimate transmissibility using patient-level data, with application to the 2015 MERS outbreak at Pyeongtaek St. Mary’s Hospital, the Republic of Korea. We developed a stochastic model based on individual case data to derive a likelihood function for disease transmission. Through scenario-based analysis, we explored transmission dynamics, including the role of superspreaders, and investigated how mask-wearing impacted infection control within the hospital. Our findings indicated that the superspreader during the MERS outbreak had approximately 25 times higher transmissibility compared to other patients. Under scenarios of prolonged hospital transmission periods, the number of cases could potentially increase threefold. The impact of mask-wearing in the hospital was significant, with reductions in the epidemic scale ranging from 17\\% to 77\\%, depending on the type of mask and intervention intensity. This study quantifies key risk factors in hospital-based transmission, demonstrating the effectiveness of intervention measures. The methodology developed here can be readily adapted to other infectious diseases, providing valuable insights for future outbreak preparedness and response strategies.

In introduction: L2-8

An epidemiological investigation is a systematic method used to determine the cause, source, and spread of a disease within a population, usually following an unusual increase in the number of cases. This process typically involves steps like verifying the outbreak, defining and identifying additional cases, using epidemiological methods to understand the disease transmission dynamics, and collecting data pertaining to cases, their characteristics, and potential risk factors.These data are directly utilized to estimate model parameters and simulate realistic outbreak patterns. This allows for evidence-based implementation of control measures to prevent further spread of the disease and reduce the risk of future outbreaks.

L13-17

For instance, during the COVID-19 pandemic in South Korea, detailed epidemiological information on individual cases—including estimated exposure dates, symptom onset dates, and reporting dates—was collected and analyzed using mathematical and statistical methods until the Omicron variant became dominant.

Reviewer #2:

Comment #1

Line 14-16: “For example, during the Coronavirus disease 2019 (COVID-19) pandemic… [8-11]”. Does the statement refer to the COVID-19 pandemic worldwide or only isolated to Korea? In the four cited references there are studies only from Korea.

Answer #1

This section was included to introduce an example of large-scale collection and analysis of individual case information during the COVID-19 pandemic. We revised it as follows (L13-17):

For instance, during the COVID-19 pandemic in South Korea, detailed epidemiological information on individual cases—including estimated exposure dates, symptom onset dates, and reporting dates—was collected and analyzed using mathematical and statistical methods until the Omicron variant became dominant.

========================================================================

Comment #2

Line 19-21: “By integrating epidemiological investigations… of model results”. Is this an assumption or a statement? If it is a statement, please add the reference.

Answer #2

We cited two new papers, along with four additional papers referenced in the previous sentence:

Shim E, Choi W, Song Y. Clinical time delay distributions of COVID-19 in 2020–2022 in the Republic of Korea: inferences from a nationwide database analysis. J Clin Med. 2022;11(12):3269.

Ko Y, Lee J, Seo Y, Jung E. Risk of COVID-19 transmission in heterogeneous age groups and effective vaccination strategy in Korea: a mathematical modeling study. Epidemiology and Health. 2021;43.

Ko Y, Lee J, Kim Y, Kwon D, Jung E. COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea. Int J Environ Res Public Health. 2021;18(12):6469.

Ko Y, Mendoza VMP, Seo Y, Lee J, Kim Y, Kwon D, et al. Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against Covid-19 epidemic in the Republic of Korea: mathematical model-based Approach considering age groups and the delta variant. Math Model Nat Phenom. 2022;17:39.

Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford university press; 1991.

Hazelbag CM, Dushoff J, Dominic EM, Mthombothi ZE, Delva W. Calibration of individual-based models to epidemiological data: A systematic review. PLoS computational biology. 2020 May 11;16(5):e1007893.

Comment #3

Line 24-27: “As a case study, we apply this method to an outbreak at Pyeongtaek… where 36 out of 186 total cases were identified [12–14]”. According to reference 12, the 186 cases (36 death and 138 recovered cases) were reported until July 26, 2015. According to figure 2 from reference 12 "Distribution of transmission of Middle East respiratory syndrome coronavirus clusters and suspected super spreaders in South Korea (20th May to 25th November 2015)" the epidemiological analysis was carried out. What is the new information presented in your study?

Answer #3

In this study, we presented insights into estimating transmission rates within the context of a specific outbreak at Pyeongtaek, utilizing general mathematical and statistical methods tailored for epidemiological investigations. We addressed the heterogeneity of hosts in a hospital environment, categorizing individuals into superspreaders, healthcare workers, patients, and visitors. This allowed us to develop a model that accurately reflects the dynamics of the outbreak and simulates realistic transmission scenarios. We also demonstrated that this method could be easily applied elsewhere. To enhance readability, we moved the section discussing “estimating transmission rate” forward and revised the sentences accordingly (L32-42).

To investigate transmission rates in detail, we categorized individuals into superspreaders, healthcare workers (HCWs), patients, and visitors based on actual epidemiological investigations. The spread in Korea was largely due to superspreaders, patients who caused secondary infections in more than six people. Of the 186 cases, it was suspected that 15 transmitted the disease to others, with five identified as superspreaders.\\\\

Simultaneously with the estimation of the transmission rate, we developed a model that reflects these investigations and simulates a realistic outbreak.A scenario-based analysis was introduced to quantify risk factors such as the infectious period of infected individuals, including superspreaders, and the effectiveness of mask mandates within the hospital.  

Comment #4

Line 27-30: “The spread in Korea… than six people [15]. Of the 186 cases, it was suspected that 15 transmitted the disease to others, with five identified as superspreaders.” The "super-spread" terminology used in the text was taken from reference 15. Please add the appropriate reference.

Answer #4

After reviewing the content, we added the following references. These studies include definitions of superspreaders, associated risks, and cases from Korea:

[Additional references]

Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005 Nov 17;438(7066):355-9.\\\\

Cho SY, Kang JM, Ha YE, Park GE, Lee JY, Ko JH, Lee JY, Kim JM, Kang CI, Jo IJ, Ryu JG. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. The Lancet. 2016 Sep 3;388(10048):994-1001.\\\\

Park JE, Jung S, Kim A, Park JE. MERS transmission and risk factors: a systematic review. BMC public health. 2018 Dec;18:1-5.

=============================================================================

Comment #5

Line 36-38: “The methodology used in this study, which relatively easily transforms the situation of hospital infections into a likelihood function, can be applied to other hospitals or infectious disease outbreaks.” Is this sentence an assumption or is it demonstrated by other articles that use this method for other infectious diseases?

Answer #5

In response to the comment, we revised it for clarity. This revision emphasizes that the methodology is not merely an assumption but is supported by its successful application in various contexts, thereby demonstrating its relevance and effectiveness in estimating transmission rates in different infectious disease scenarios. The updated version (L42-49) states:

The methodology employed in this study transforms the dynamics of hospital infections into a likelihood function, allowing for its application to other hospitals or infectious disease outbreaks. By focusing on the estimation of transmission rates among heterogeneous hosts in certain spaces like hospitals, we expect these findings to significantly enhance both reactive and preventive measures. This approach, which has been successfully utilized in various contexts, including human-to-human and animal-to-animal infectious diseases, underscores the potential for improving infection control strategies

[Additional references]

Keeling MJ, Woolhouse ME, Shaw DJ, Matthews L, Chase-Topping M, Haydon DT, Cornell SJ, Kappey J, Wilesmith J, Grenfell BT. Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science. 2001 Oct 26;294(5543):813-7.

Boender GJ, Hagenaars TJ, Bouma A, Nodelijk G, Elbers AR, de Jong MC, Van Boven M. Risk maps for the spread of highly pathogenic avian influenza in poultry. PLoS computational biology. 2007 Apr;3(4):e71.

Comment #6

Line 230-234: “The overall methodology of this study can be applied to other outbreak situations… to the specific conditions in future outbreak situations.” Considering that the present study was submitted in 2024, after the WHO declared that the COVID-19 pandemia had ended, I would have liked you to compare MERS and SARS-CoV-2 in the perspective in which the methodology used can be inter-connected.

Answer #6

In the Republic of Korea, during the early stages of the COVID-19 pandemic, there were several reports of outbreaks in closed environments such as hospitals, nursing homes, and correctional facilities. If we can obtain individual case data specific to each location, it seems feasible to apply this methodology. Taking this comment into account, I will aim to conduct comparative studies in the future when we have processed data categorized by space. We added following sentence in discussion section (L253-259)

Additionally, our methodology could be adapted to other outbreaks in closed settings, such as those documented early in the COVID-19 pandemic in the Republic of Korea, in environments like hospitals, nursing homes, and correctional facilities. With access to individual case data specific to each location, we believe our approach could be effectively applied to analyze similar scenarios. Furthermore, as recorded in endemic regions, future studies will highlight the transmission pathways moving from environmental sources to humans and subsequently to healthcare facilities.

[Added references]

Lee HA, Ahn MH, Byun S, Lee HK, Kweon YS, Chung S, Shin YW, Lee KU. How COVID-19 affected healthcare workers in the hospital locked down due to early COVID-19 cases in Korea. Journal of Korean Medical Science. 2021 Dec 6;36(47).

Giri S, Chenn LM, Romero-Ortuno R. Nursing homes during the COVID-19 pandemic: a scoping review of challenges and responses. European Geriatric Medicine. 2021 Dec;12(6):1127-36.

Lee HY, Park YJ, Yu M, Park H, Lee JJ, Choi J, Park HS, Kim JY, Moon JY, Lee SE. Accuracy of rapid antigen screening tests for SARS-CoV-2 infection at correctional facilities in Korea: March-May 2022. Infection \\& Chemotherapy. 2023 Dec;55(4):460.

Reviewer #3:

Comment #1

It is well known that the MERS outbreak in South Korea was an explosive outbreak in healthcare settings which needs more demonstrated in the text and added in the model. The outbreak largely relied on the patient's health-seeking behaviors, so it should be reflected in their model.

Answer #1

In the actual 2015 MERS outbreak, health-seeking behaviors (also referred to as “doctor shopping”) contributed to the spread across multiple hospitals. In our study, however, we limited the model to a single hospital (Pyeongtaek St. Mary's Hospital) and did not consider this behavior. In reality, case #14, responsible for further spread, was initially infected at Pyeongtaek and subsequently admitted to a larger hospital (Samsung Medical Center), where subsequent transmissions occurred. We believe that health-seeking behaviors could be effectively addressed in an advanced model that considers both hospitals and the community. To address this comment, we have added the following statement in the Discussion section (L239-259):

In this study, we focused on a single hospital context and did not include health-seeking behaviors—such as visiting multiple healthcare facilities, often called 'doctor shopping'—which significantly contributed to the cross-hospital spread during the 2015 MERS outbreak in the Republic of Korea. Addressing this and other complexities, such as detailed spatial arrangements, individual patient tracking, isolation and testing procedures, and infections involving HCWs, would allow for a more comprehensive model. Future work will expand on these elements, incorporating diverse transmission types and behaviors to better capture the dynamics of healthcare-associated outbreaks.

Additionally, our methodology could be adapted to other outbreaks in closed settings, such as those documented early in the COVID-19 pandemic in the Republic of Korea, in environments like hospitals, nursing homes, and correctional facilities. With access to individual case data specific to each location, we believe our approach could be effectively applied to analyze similar scenarios. Furthermore, as recorded in endemic regions, future studies will highlight the transmission pathways moving from environmental sources to humans and subsequently to healthcare facilities.

[Additional references]

Kim SW, Park JW, Jung HD, Yang JS, Park YS, Lee C, Kim KM, Lee KJ, Kwon D, Hur YJ, Choi B. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clinical Infectious Diseases. 2017 Mar 1;64(5):551-7.  

Comment #2

The transmission also relies on the viral shedding in the infector and infectee; thus this factor should be reflected in the author's model.

Answer #2

In our study, the transmission rate incorporates both the number of contacts per unit time and the probability of infection following those contacts. This naturally includes viral shedding. We have accounted for host heterogeneity, which can vary based on factors such as distance from the infector and contact frequency, even if the shedding remains constant among infectors. To reflect this aspect, we have revised the text in section L88-93 as follows:

Infectious hosts transmit the disease through viral shedding. We assumed that there is heterogeneity in the successful transmission based on contact frequency, duration, and distance between the infectee and infector, considering the types of hosts (HCWs, patients, and visitors) within the hospital setting.

=============================================================================

Comment #3

I would strongly recommend the author read the

Attachment

Submitted filename: Reviewers comments.docx

pone.0317083.s002.docx (39.7KB, docx)

Decision Letter 1

Yury E Khudyakov

22 Dec 2024

Mathematical and Statistical Approaches in Epidemiological Investigation of Hospital Infection: A Case Study of the 2015 Middle East Respiratory Syndrome Outbreak in Korea

PONE-D-24-28130R1

Dear Dr. Jung,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yury E Khudyakov, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Amos Ssematimba

Reviewer #2: No

**********

Acceptance letter

Yury E Khudyakov

13 Jan 2025

PONE-D-24-28130R1

PLOS ONE

Dear Dr. Jung,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yury E Khudyakov

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Reviewer report_PONE-D-24-28130.docx

    pone.0317083.s001.docx (16.7KB, docx)
    Attachment

    Submitted filename: Reviewers comments.docx

    pone.0317083.s002.docx (39.7KB, docx)

    Data Availability Statement

    The data that support the findings of this study are openly available in figshare at https://doi.org/10.6084/m9.figshare.25981987.v1.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES